NCT04086082

Markerless Image Guidance Using Intrafraction Kilovoltage X-ray Imaging

MAGIK: Using Implanted Markers to Determine the Feasibility of Markerless Image Guidance Using Intrafraction Kilovoltage X-ray Imaging: A Phase I Interventional Study of Lung Cancer Radiotherapy

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: University of Sydney · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This trial will investigate the feasibility of the Markerless Tumour Tracking technology.

Detailed description

Markerless Tumour Tracking will be integrated with existing treatment machines to provide real-time monitoring of tumour motion during treatment delivery. Eligible patients will be implanted with fiducial markers, which act as the ground truth for evaluating the accuracy of Markerless Tumour Tracking. The patients will undergo the current standard of care radiotherapy, with the exception that kilovoltage x-ray images will be acquired continuously during treatment delivery to enable Markerless Tumour Tracking.

Conditions

• Lung Cancer

Interventions

Type	Name	Description
DEVICE	Markerless Image Guidance	Single arm trial using implanted markers to determine the feasibility of Markerless Image Guidance using Intrafraction Kilovoltage X-ray Imaging

Timeline

• Start date: 2023-05-24
• Primary completion: 2024-12-01
• Completion: 2028-12-01
• First posted: 2019-09-11
• Last updated: 2024-01-11

Locations

1 site across 1 country: Australia